Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Kathryn Ann Martin, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. F32HD007198 (MARTIN, KATHRYN A) Jan 10, 1989
    Role: Principal Investigator
  2. M01RR001066 (SLAVIN, PETER L) Feb 1, 1978 - May 31, 2008
    General Clinical Research Center
    Role: Co-Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Delaney A, Burkholder AB, Lavender CA, Plummer L, Mericq V, Merino PM, Quinton R, Lewis KL, Meader BN, Albano A, Shaw ND, Welt CK, Martin KA, Seminara SB, Biesecker LG, Bailey-Wilson JE, Hall JE. Increased Burden of Rare Sequence Variants in GnRH-Associated Genes in Women With Hypothalamic Amenorrhea. J Clin Endocrinol Metab. 2021 03 08; 106(3):e1441-e1452. PMID: 32870266; PMCID: PMC7947783.
    Citations:    Fields:    Translation:Humans
  2. Barrionuevo P, Nabhan M, Altayar O, Wang Z, Erwin PJ, Asi N, Martin KA, Murad MH. Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis. J Clin Endocrinol Metab. 2018 04 01; 103(4):1258-1264. PMID: 29522176.
    Citations: 6     Fields:    Translation:Humans
  3. Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH, Pugeat MM, Rosenfield RL. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018 04 01; 103(4):1233-1257. PMID: 29522147.
    Citations: 41     Fields:    Translation:Humans
  4. Santoro N, Braunstein GD, Butts CL, Martin KA, McDermott M, Pinkerton JV. Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab. 2016 Apr; 101(4):1318-43. PMID: 27032319.
    Citations: 6     Fields:    Translation:Humans
  5. Vigersky RA, Bhasin S, Martin KA. The Endocrine Society Clinical Practice Guidelines: a self-assessment. J Clin Endocrinol Metab. 2013 Aug; 98(8):3174-7. PMID: 23801367.
    Citations: 1     Fields:    Translation:Humans
  6. Abel BS, Shaw ND, Brown JM, Adams JM, Alati T, Martin KA, Pitteloud N, Seminara SB, Plummer L, Pignatelli D, Crowley WF, Welt CK, Hall JE. Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2013 Feb; 98(2):E206-16. PMID: 23341491; PMCID: PMC3565114.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  7. Sidhoum VF, Chan YM, Lippincott MF, Balasubramanian R, Quinton R, Plummer L, Dwyer A, Pitteloud N, Hayes FJ, Hall JE, Martin KA, Boepple PA, Seminara SB. Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system. J Clin Endocrinol Metab. 2014 Mar; 99(3):861-70. PMID: 24423288; PMCID: PMC3942233.
    Citations: 55     Fields:    Translation:Humans
  8. Chan YM, Broder-Fingert S, Paraschos S, Lapatto R, Au M, Hughes V, Bianco SD, Min L, Plummer L, Cerrato F, De Guillebon A, Wu IH, Wahab F, Dwyer A, Kirsch S, Quinton R, Cheetham T, Ozata M, Ten S, Chanoine JP, Pitteloud N, Martin KA, Schiffmann R, Van der Kamp HJ, Nader S, Hall JE, Kaiser UB, Seminara SB. GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1. J Clin Endocrinol Metab. 2011 Nov; 96(11):E1771-81. PMID: 21880801; PMCID: PMC3205899.
    Citations: 27     Fields:    Translation:HumansAnimals
  9. Caronia LM, Martin C, Welt CK, Sykiotis GP, Quinton R, Thambundit A, Avbelj M, Dhruvakumar S, Plummer L, Hughes VA, Seminara SB, Boepple PA, Sidis Y, Crowley WF, Martin KA, Hall JE, Pitteloud N. A genetic basis for functional hypothalamic amenorrhea. N Engl J Med. 2011 Jan 20; 364(3):215-25. PMID: 21247312; PMCID: PMC3045842.
    Citations: 57     Fields:    Translation:Humans
  10. Shaw ND, Seminara SB, Welt CK, Au MG, Plummer L, Hughes VA, Dwyer AA, Martin KA, Quinton R, Mericq V, Merino PM, Gusella JF, Crowley WF, Pitteloud N, Hall JE. Expanding the phenotype and genotype of female GnRH deficiency. J Clin Endocrinol Metab. 2011 Mar; 96(3):E566-76. PMID: 21209029; PMCID: PMC3047229.
    Citations: 42     Fields:    Translation:Humans
  11. Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010 Jul; 95(7 Suppl 1):s1-s66. PMID: 20566620; PMCID: PMC6287288.
    Citations: 140     Fields:    Translation:Humans
  12. Webb T, Martin K, Afifi AA, Kraus J. Media literacy as a violence-prevention strategy: a pilot evaluation. Health Promot Pract. 2010 Sep; 11(5):714-22. PMID: 19182263.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  13. Martin KA, Manson JE. Approach to the patient with menopausal symptoms. J Clin Endocrinol Metab. 2008 Dec; 93(12):4567-75. PMID: 19056840.
    Citations: 16     Fields:    Translation:Humans
  14. Matsumoto AM, Snyder PJ, Bhasin S, Martin K, Weber T, Winters S, Spratt D, Brentzel J, O'Dea L. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertil Steril. 2009 Sep; 92(3):979-990. PMID: 18930190.
    Citations: 14     Fields:    Translation:HumansCellsCTClinical Trials
  15. Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, Shapiro J, Montori VM, Swiglo BA. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008 Apr; 93(4):1105-20. PMID: 18252793.
    Citations: 60     Fields:    Translation:Humans
  16. Cerrato F, Shagoury J, Kralickova M, Dwyer A, Falardeau J, Ozata M, Van Vliet G, Bouloux P, Hall JE, Hayes FJ, Pitteloud N, Martin KA, Welt C, Seminara SB. Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism. Eur J Endocrinol. 2006 Nov; 155 Suppl 1:S3-S10. PMID: 17074994.
    Citations: 32     Fields:    Translation:Humans
  17. Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, Martin KA. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause. 2006 May-Jun; 13(3):411-22. PMID: 16735938.
    Citations: 93     Fields:    Translation:Humans
  18. Welt CK, Falorni A, Taylor AE, Martin KA, Hall JE. Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels. J Clin Endocrinol Metab. 2005 May; 90(5):3069-76. PMID: 15705922.
    Citations: 16     Fields:    Translation:HumansCells
  19. Meysing AU, Kanasaki H, Bedecarrats GY, Acierno JS, Conn PM, Martin KA, Seminara SB, Hall JE, Crowley WF, Kaiser UB. GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone. J Clin Endocrinol Metab. 2004 Jul; 89(7):3189-98. PMID: 15240592.
    Citations: 22     Fields:    Translation:HumansCells
  20. Turgeon JL, McDonnell DP, Martin KA, Wise PM. Hormone therapy: physiological complexity belies therapeutic simplicity. Science. 2004 May 28; 304(5675):1269-73. PMID: 15166356.
    Citations: 78     Fields:    Translation:HumansAnimalsCells
  21. Martin KA. Hormone Replacement Therapy: What Now?. Endocrinology Rounds. 2003; 2(June-July):6.
  22. Welt CK, Taylor AE, Martin KA, Hall JE. Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone. J Clin Endocrinol Metab. 2002 Dec; 87(12):5559-65. PMID: 12466353.
    Citations: 10     Fields:    Translation:Humans
  23. Perkins RB, Hall JE, Martin KA. Aetiology, previous menstrual function and patterns of neuro-endocrine disturbance as prognostic indicators in hypothalamic amenorrhoea. Hum Reprod. 2001 Oct; 16(10):2198-205. PMID: 11574516.
    Citations: 9     Fields:    Translation:Humans
  24. Manson JE, Martin KA. Clinical practice. Postmenopausal hormone-replacement therapy. N Engl J Med. 2001 Jul 05; 345(1):34-40. PMID: 11439947.
    Citations: 27     Fields:    Translation:Humans
  25. Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, Hall JE. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001 Jun; 86(6):2428-36. PMID: 11397835.
    Citations: 2     Fields:    Translation:Humans
  26. Beranova M, Oliveira LM, Bédécarrats GY, Schipani E, Vallejo M, Ammini AC, Quintos JB, Hall JE, Martin KA, Hayes FJ, Pitteloud N, Kaiser UB, Crowley WF, Seminara SB. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2001 Apr; 86(4):1580-8. PMID: 11297587.
    Citations: 62     Fields:    Translation:HumansAnimalsCells
  27. Bo-Abbas YY, Martin KA, Liberman RF, Cramer DW, Barbieri RL. Serum and follicular fluid hormone levels during in vitro fertilization after short- or long-course treatment with a gonadotropin-releasing hormone agonist. Fertil Steril. 2001 Apr; 75(4):694-9. PMID: 11287021.
    Citations:    Fields:    Translation:Humans
  28. Hall JE, Lavoie HB, Marsh EE, Martin KA. Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women. J Clin Endocrinol Metab. 2000 May; 85(5):1794-800. PMID: 10843154.
    Citations: 34     Fields:    Translation:Humans
  29. Seminara SB, Beranova M, Oliveira LM, Martin KA, Crowley WF, Hall JE. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations. J Clin Endocrinol Metab. 2000 Feb; 85(2):556-62. PMID: 10690855.
    Citations: 27     Fields:    Translation:HumansCells
  30. Gill S, Taylor A, Martin KA, Welt C, Adams J, Hall JE . Predictive factors of the responsiveness to pulsatile GnRH therapy in polycystic ovarian syndrome. Massachusetts General Hospital XXIV Research Symposium, Boston. 2000.
  31. Martin K. Controversies in postmenopausal hormone replacement. Current Opinion in Endocrinology and Diabetes. 2000; 7:325-331.
  32. Taylor A, Hall JE, Adams JM, Martin KA, Welt CW, Crowley WF Jr. The physiology of the human midcycle gonadotropin surge. Proceedings of the International Symposium on Ovulation: Evolving Scientific and Clinical Concepts. E Adahi (ed). 2000.
  33. Perkins RB, Hall JE, Martin KA. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation. J Clin Endocrinol Metab. 1999 Jun; 84(6):1905-11. PMID: 10372685.
    Citations: 17     Fields:    Translation:HumansCTClinical Trials
  34. Seminara SB, Hall JE, Taylor AE, Crowley WF, Martin KA. The Reproductive Endocrine Associates of the Massachusetts General Hospital: fifteen years of integrated clinical practice and investigation. J Clin Endocrinol Metab. 1999 Jun; 84(6):1912-8. PMID: 10372686.
    Citations:    Fields:    Translation:Humans
  35. Sharpless JL, Supko JG, Martin KA, Hall JE. Disappearance of endogenous luteinizing hormone is prolonged in postmenopausal women. J Clin Endocrinol Metab. 1999 Feb; 84(2):688-94. PMID: 10022439.
    Citations: 9     Fields:    Translation:Humans
  36. Martin KA, Rosen HN. Overview of estrogen replacement therapy. In: UptoDate in Medicine. Burton Rose, Editor-in Chief. UpToDate, Inc. 1999.
  37. Martin, KA. Hormone replacement therapy: Therapeutic dilemmas. In: Advanced medical endocrinology for clinical practice (pp. 173-181). 1999.
  38. Martin, KA. Practical management issues in hormone replacement therapy. In: Clinical Endocrinology Update (pp. 257-264). 1999.
  39. Martin KA. Estrogen Therapy for the Menopause. Proceedings of the International Symposium on Endocrine and Molecular Interventions in Aging. 1999.
  40. Martin, KA. Male hypogonadism. In: Advanced medical endocrinology for clinical practice (pp. 199-207). 1999.
  41. Martin KA. Menopause and hormone replacement therapy. Lifestyle Medicine. Rippe JM eds. 1999; 27:303-311.
  42. Martin, KA. . , 1999, pp. 119-122. Hyperprolactinemia. In: Advanced medical endocrinology for clinical practice (pp. 119-122). 1999.
  43. Martin, KA. Hormone replacement therapy: Therapeutic dilemmas In: Clinical Endocrinology Update (pp. 239-246). 1999.
  44. Hayes FJ, Taylor AE, Martin KA, Hall JE. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics. J Clin Endocrinol Metab. 1998 Jul; 83(7):2343-9. PMID: 9661606.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  45. Martin KA, Welt CK, Taylor AE, Smith JA, Crowley WF, Hall JE. Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model. Neuroendocrinology. 1998 Jun; 67(6):363-9. PMID: 9662715.
    Citations: 5     Fields:    Translation:Humans
  46. Martin, KA. Hormone replacement therapy. Common problems. In: Clinical Endocrinology Update (pp. 209-216). 1998.
  47. Taylor AE, Martin KA, Adams JM, Hall JE. The Role of LH Excess in Polycystic Ovary Syndrome. Endocrine Society Annual Meeting, New Orleans, LA. 1998.
  48. Martin, KA. Postmenopausal hormone replacement: Difficult decisions. In: Clinical Endocrinology Update (pp. 175-182). 1998.
  49. Martin KA, Hall JE. Pulsatile GnRH in Hypogonadotropic Hypogonadism. Ovulation Induction Update ’98. Proceedings of the 2nd World Conference on Ovulation Induction. Filicori and Flamigni, editors. 1998.
  50. Lavoie HB, Martin KA, Rowbotham CE, Hall JE. Sleep Associated Inhibition of the GnRH Pulse Generator in Postmenopausal Women is Not Affected by Aging. Endocrine Society Annual Meeting, New Orleans, LA. 1998.
  51. Martin KA, Korenman S, Pappas F, Fuh V. Effects of an Oral Growth Hormone (GH) Secretagogue on the H-P-Gonadal Axis (HPG-Axis). Endocrine Society Annual Meeting, New Orleans, LA. 1998.
  52. Hall JE, Taylor AE, Martin KA. Body weight and gonadotropin secretion in normal women and women with reproductive abnormalities. Nutrition and Reproduction, Wm Hansel, G Bray and D Ryan (eds). 1998; 378-393.
  53. Garnick MB, Moseley W, Murdock M, Brosman S, Sluss P, Martin K et al. . . Abarelix-Depot, A Sustained Release Formulation of a Potent GnRH Pure Antagonist in Patients with Prostate Cancer: Initial Clinical Results with Endocrine Comparison with Superagonists Lupron and Zoladex. Endocrine Society Annual Meeting, New Orleans, LA. 1998.
  54. Lavoie HB, Martin KA, Taylor E, Crowley WF, Hall JE. Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1998 Jan; 83(1):241-7. PMID: 9435449.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  55. Martin KA, Hornstein MD, Taylor AE, Hall JE, Barbieri RL. Exogenous gonadotropin stimulation is associated with increases in serum androgen levels in in-vitro fertilization-embryo transfer cycles. Fertil Steril. 1997 Dec; 68(6):1011-6. PMID: 9418689.
    Citations: 1     Fields:    Translation:Humans
  56. Welt CK, Martin KA, Taylor AE, Lambert-Messerlian GM, Crowley WF, Smith JA, Schoenfeld DA, Hall JE. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. J Clin Endocrinol Metab. 1997 Aug; 82(8):2645-52. PMID: 9253348.
    Citations: 13     Fields:    Translation:Humans
  57. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997 Jul; 82(7):2248-56. PMID: 9215302.
    Citations: 112     Fields:    Translation:Humans
  58. Lavoie HB, Marsh EE, Martin KA, Hall JE. . . Circadian Rhythm of Gonadotropin and Free Alpha Subunit in Postmenopausal Women: Effect of Aging. Endocrine Society Annual Meeting, Minneapolis, MN. 1997.
  59. Taylor AE, Martin KA, Hall JE . Evidence for a Reproductive Role of Leptin: Correlation with LH Pulse Amplitude but not Frequency in Normal Women and Polycystic Ovary Syndrome. Endocrine Society Annual Meeting. Minneapolis, MN. 1997.
  60. Taylor AE, Adams JM, Mulder JE, Martin KA, Sluss PM, Crowley WF. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab. 1996 Oct; 81(10):3615-21. PMID: 8855811.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  61. Christin-Maitre S, Taylor AE, Khoury RH, Hall JE, Martin KA, Smith PC, Albanese C, Jameson JL, Crowley WF, Sluss PM. Homologous in vitro bioassay for follicle-stimulating hormone (FSH) reveals increased FSH biological signal during the mid- to late luteal phase of the human menstrual cycle. J Clin Endocrinol Metab. 1996 Jun; 81(6):2080-8. PMID: 8964832.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  62. Taylor AE, Adams JM, Martin KA, Hall JE. Prospective Evaluation of Consensus Criteria for Polycystic Ovary Syndrome: Evidence for Subgroups Characterized by Inverse Defects of LH and Insulin. 10th International Congress of Endocrinology, San Francisco, CA. 1996.
  63. Taylor A, Hall J, Martin K, Crowley WF Jr. Deranged gonadotropin secretion and hyperandrogenism. The Ovary: Regulation, Dysfunction and Treatment. Marco Island, FL. 1996.
  64. Martin KA. Therapeutic dilemmas in postmenopausal hormone replacement therapy. In: Clinical Endocrinology Update (pp. 85-90). 1996.
  65. Adams J, Taylor A, Martin K, Hall J. Pelvic Ultrasound: PCO vs Multifollicular Ovaries. The Ovary: Regulation, Dysfunction and Treatment. Marco Island, FL. 1996.
  66. Hall JE, Taylor AE, Martin KA, Adams JM, Khoury R, Schneyer AL, Sluss PM, Crowley WF. . . Inhibin B in Polycystic Ovarian Syndrome (PCOS). 10th International Congress of Endocrinology, 1996, San Francisco, CA. 1996.
  67. Martin KA. Practical aspects of hormone replacement therapy. In Clinical Endocrinology Update (pp. 117-124). 1996.
  68. Hall JE, Martin KA, Taylor AE, Khoury R, Sluss P, Lambert-Messerlian, Schneyer AL, Crowley WF. . . Reciprocal Changes in Inhibin B and Inhibin A During the Normal Menstrual Cycle. 10th International Congress of Endocrinology, 1996, San Francisco, CA. 1996.
  69. Martin KA. Menstrual cycle disorders. In: Clinical Endocrinology Update (p. 148-154). 1996.
  70. Khoury RH, Boepple PB, Hall JE, Taylor AE, Martin KA, Schneyer AL, Crowley WF, Sluss P. . . Performance characteristics of the Serotec inhibin B ELISA in studies of human physiology and pathophysiology. 16th International Congress of Clinical Chemistry, London, UK. 1996.
  71. Taylor AE, Whitney H, Hall JE, Martin K, Crowley WF. Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women. J Clin Endocrinol Metab. 1995 May; 80(5):1541-7. PMID: 7744998.
    Citations: 12     Fields:    Translation:Humans
  72. Martin K. , in . , 1995; 36:251-256. Menopause and Estrogen Replacement Therapy. Primary Care Of Women, Carlson K and Eisenstadt S, eds. 1995; 36:251-256.
  73. Hall JE, Martin KA, Whitney HA, Landy H, Crowley WF. Potential for fertility with replacement of hypothalamic gonadotropin-releasing hormone in long term female survivors of cranial tumors. J Clin Endocrinol Metab. 1994 Oct; 79(4):1166-72. PMID: 7962290.
    Citations: 5     Fields:    Translation:Humans
  74. Hall JE, Taylor AE, Martin KA, Rivier J, Schoenfeld DA, Crowley WF. Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women. Proc Natl Acad Sci U S A. 1994 Jul 19; 91(15):6894-8. PMID: 8041716; PMCID: PMC44304.
    Citations: 17     Fields:    Translation:HumansCells
  75. Lambert-Messerlian GM, Hall JE, Sluss PM, Taylor AE, Martin KA, Groome NP, Crowley WF, Schneyer AL. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab. 1994 Jul; 79(1):45-50. PMID: 8027251.
    Citations: 8     Fields:    Translation:Humans
  76. Sluss PM. Khoury RH, Pavlou S, Pralong F, Martin KA, Hall JE, Taylor AE, Schneyer AL, Crowley WF Jr. . #513. Serum Concentrations of Human Follistatin (FS) Reflect Pituitary Function. Endocrine Society Annual Meeting, Anaheim, CA; #513. 1994.
  77. Taylor AE, Sluss P, Martin K, Mulder J, Christin S, Albanese C, Adams JM, Jameson JL, Crowley WF Jr. A Majority of Women with Premature Ovarian Failure Have Low FSH Bioactivity. Clinical Research. 1994; 42:270A.
  78. Martin KA. Hormone replacement therapy in women. In: Clinical Endocrinology Update (p. 115-119). 1994.
  79. Martin KA . 19, 1994, 4. Growth Hormone and Infertility. Resolve National Newsletter. 1994; 19:4.
  80. Crowley WF, Taylor AE, Martin KA, Whitcomb RW, Finkelstein JS, and Hall JE. Use of the free alpha subunit (FAS) of glycoprotein secreting hormones as a surrogate marker of GnRH secretion in the human. Glycoprotein Hormones: Structure, Function, and Clinical Implications (Joyce W. Lustbader, J David Puett, and Raymond Ruddon, editors). Serono Symposia USA. 1994; 253-263.
  81. Martin KA, Hall JE, Adams J, Crowley WF Jr. . In: 1994; B.V.255-266. Pulsatile GnRH in Hypogonadotropic Hypogonadism. Ovulation Induction: Basic Science and Clinical Advances. M Filicori and Flamigni, editors. International Congress Series 1046; Excerpta Medica. 1994; 255-266.
  82. Martin KA, Whitney H, Adams J, Crowley WF, Jr. Pulsatile GnRH for Controlled Amplification of Folliculogenesis in Normal Women. Ovulation Induction: Basic Science and Clinical Advances, Palm Beach, Florida. 1994.
  83. Martin KA, Hall JE, Adams JM, Crowley WF. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 1993 Jul; 77(1):125-9. PMID: 8325934.
    Citations: 16     Fields:    Translation:Humans
  84. Hall JE, Taylor AE, Martin KA, Crowley WF. New approaches to the study of the neuroendocrine abnormalities of women with the polycystic ovarian syndrome. Ann N Y Acad Sci. 1993 May 28; 687:182-92. PMID: 8323172.
    Citations: 2     Fields:    Translation:Humans
  85. Crowley WF, Hall JE, Martin KA, Adams J, Taylor AE. An overview of the diagnostic considerations in polycystic ovarian syndrome. Ann N Y Acad Sci. 1993 May 28; 687:235-41. PMID: 8323178.
    Citations: 1     Fields:    Translation:Humans
  86. Martin KA, Freeman MW. Postmenopausal hormone-replacement therapy. N Engl J Med. 1993 Apr 15; 328(15):1115-7. PMID: 8455670.
    Citations: 4     Fields:    Translation:Humans
  87. Sluss PM, Gentile DP, Ewing JF, Schoen SR, Cockett AT, Martin KA, Schneyer AL. Multiple molecular weight forms of immunoreactive alpha-inhibin in human seminal plasma. J Clin Endocrinol Metab. 1993 Feb; 76(2):476-83. PMID: 8432793.
    Citations:    Fields:    Translation:Humans
  88. Martin KA, Freeman MW. Postmenopausal Hormone-Replacement Therapy (Editorial). NEJM. 1993; 328:1115-1117.
  89. Crowley WF, Jr, Hall J, Martin K, Adams J, Taylor A. An Overview of the Diagnostic Considerations in Polycystic Ovarian Syndrome. Annals NY Acad Science. 1993; 687:235-241.
  90. Hall JE, Schoenfeld DA, Martin KA, Crowley WF. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinol Metab. 1992 Mar; 74(3):600-7. PMID: 1740493.
    Citations: 21     Fields:    Translation:Humans
  91. Hall J, Taylor A, Martin K, Crowley WF Jr. Neuroendocrine Investigation: New Approaches. Polycystic Ovary Syndrome (Dunaif A, Givens J, Merriam G, Haseltine F., editors. 1992; 4:39-50.
  92. Martin KA. Menopausal estrogen replacement. In: Clinical Endocrinology Update (p. 478-486). 1992.
  93. Schneyer AL, Sluss PM, Whitcomb RW, Martin KA, Sprengel R, Crowley WF. Precursors of alpha-inhibin modulate follicle-stimulating hormone receptor binding and biological activity. Endocrinology. 1991 Oct; 129(4):1987-99. PMID: 1915079.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  94. Martin K, Santoro N, Hall J, Filicori M, Wierman M, Crowley WF. Clinical review 15: Management of ovulatory disorders with pulsatile gonadotropin-releasing hormone. J Clin Endocrinol Metab. 1990 Nov; 71(5):1081A-1081G. PMID: 2229271.
    Citations: 18     Fields:    Translation:Humans
  95. Graham MC, Sluss PM, Schneyer AL, Martin KA. . , ; 0-054,S23. Differences in Molecular Weight Forms of Immunoreactive Alpha Inhibin in Follicles of In Vitro Fertilization Patients. American Fertility Society Annual Meeting,Washington, DC. 1990; S23:0-054.
  96. Hopkins CC, Hall JE, Santoro NF, Martin KA, Filicori M, Crowley WF. Closed intravenous administration of gonadotropin-releasing hormone: safety of extended peripheral intravenous catheterization. Obstet Gynecol. 1989 Aug; 74(2):267-70. PMID: 2664612.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Martin's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (247)
Co-Authors (22)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.